Apr 23
Blog Post: Investors, Pernix Set $75M Stalking Horse Bid For Orexigen
by Anonymous
The bankrupt obesity-drug maker Orexigen Therapeutics Inc. on Monday said it will likely sell its business to Nalpropion Pharmaceuticals, which was just formed by an investor group and Pernix Therapeutics Holdings Inc., for a $75 million stalking horse bid.
Click to see full article
Click to see full article
